The Marburg I polymorphism of factor VII-activating protease and the risk of venous thromboembolism [3]

Thrombosis and Haemostasis

Volumn 97, Issue 5, 2007, Pages 870-872

  Weisbach, Volker ^a   Ruppel, Renate ^a   Eckstein, Reinhold ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7 ACTIVATING PROTEASE; PROTEINASE; PROUROKINASE; UNCLASSIFIED DRUG;

BLOOD DONOR; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; HUMAN; LETTER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; SERINE ENDOPEPTIDASES; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 34248999092     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-12-0739     Document Type: Letter

References (10)

1. Römisch I FVII activating protease (FSAP): novel protease in haemostasis. Biol Chem 2002; 383: 1119-1124.
2. Hoppe B, Tolou F, Radtke H, et al. Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism. Blood 2005; 105: 1549-1551.
3. van Minkelen R, de Visser MCH, Vos HL, et al. The Marburg I polymorphism of factor VH-activating protease is not associated with venous thrombosis. Blood 2005; 105: 4898-4899.
4. Franchi F, Martinelli I, Biguzzi E, et al. Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism. Blood 2006; 107: 1731.
5. Hoppe B, Heymann GA, Radtke H, et al. Association of Marburg I polymorphism of factor VH-activating protease with venous thromboembolism is limited to idiopathic events. Blood 2005; 105: 4899.
6. Gulesserian T, Hron G, Endler G, et al. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 2006; 95: 65-67.
7. Hoppe B, Dorner T, Kiesewetter H, et al. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 2006; 95: 907-908.
8. Kyrle PA. Response to: Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 2006; 95: 908.
9. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
10. Poort SR, Rosendaal FR, Reitsma PH, et al, A common genetic variation in the 3V-untranslated region of the prothrombin gene is associated with elevaled plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.